Snowball logo
logo
4582

SymBio Pharmaceuticals Ltd

4582 TSE
¥55.00-¥2.00  (3.51%)
Estimate
EPS
-96.66
Beta
0.525
Growth
Revenue, YoY
-38.19%
Net income, YoY
-16.3%
About the company
Ticker
4582
ISIN
JP3383050006
Country
Japan
Sector (GICS)
Healthcare
SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases; SyB L-1701, an RTD liquid formulation; and SyB L-1702, an RI administration under the TREAKISYM name. The company was incorporated in 2005 and is based in Minato, Japan.

Frequently asked questions

What sector does SymBio Pharmaceuticals Ltd (4582) operate in?

SymBio Pharmaceuticals Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is SymBio Pharmaceuticals Ltd (4582) current stock price?

As of the latest data, SymBio Pharmaceuticals Ltd stock price is ¥55, with a previous close of ¥57. SymBio Pharmaceuticals Ltd lost -¥2 in the last trading session, representing a -3.51% loss.

What is SymBio Pharmaceuticals Ltd (4582) current market capitalization?

SymBio Pharmaceuticals Ltd market cap is approximately 4.41 billion.

What is SymBio Pharmaceuticals Ltd (4582) Earnings Per Share (EPS)?

The trailing EPS is -¥97.

What is SymBio Pharmaceuticals Ltd (4582) EBITDA?

SymBio Pharmaceuticals Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -1.29 billion.

Does SymBio Pharmaceuticals Ltd (4582) pay dividends?

No. SymBio Pharmaceuticals Ltd does not pay a dividend.

When is SymBio Pharmaceuticals Ltd (4582) next earnings report?

SymBio Pharmaceuticals Ltd is expected to release its next earnings report on June 30, 2026.

What is SymBio Pharmaceuticals Ltd (4582) beta (volatility) score?

SymBio Pharmaceuticals Ltd has a beta of 0.525, indicating lower volatility than the overall market.